Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.
about
A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosisDown-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neuronsGene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody productionInteraction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in miceThe role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.The antiapoptotic activity of melatonin in neurodegenerative diseases.Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesisExpression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortexConcerted perturbation observed in a hub network in Alzheimer's diseaseCellular FLICE-inhibitory protein: an attractive therapeutic target?The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics StrategiesFamilial cortical myoclonus with a mutation in NOL3.Genetics, transcriptomics, and proteomics of Alzheimer's diseaseNeuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection.Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell deathDecreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample.Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.p53-Dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity.Overexpression of caspase-9 triggers its activation and apoptosis in vitro.Screening of mutations in NOL3 in a myoclonic syndromes series.Repositioning Microtubule Stabilizing Drugs for Brain DisordersProfiles of teleost DNA fragmentation factor alpha and beta from rock bream (Oplegnathus fasciatus): molecular characterization and genomic structure and gene expression in immune stress
P2860
Q24321576-B5E2DC26-33B8-49B7-A94A-A8C40B05E0BBQ24633872-24E57FB5-F186-47A4-8284-65A1DB227EF3Q30496834-3350F6C5-AC34-4F6F-B37D-70CB9FC4879AQ33569701-C2E22A9F-CD78-45F2-AEFA-7A01A4C97AEEQ33629783-B35F15E8-D57C-4316-AD33-A632BEB31FEBQ33757816-48CCB621-AA54-4B0E-963D-5111DD61A8E3Q34063866-233FD589-1023-48D2-8ECA-EF31751EC5E1Q34099046-F8961F87-0027-4382-A4E4-0DEAE2C011A7Q34344867-594A343D-376B-4F69-A82E-964AE5F27E61Q35186676-BE199730-2B89-460F-A387-792750EB7595Q35542836-057CF02A-E3D3-4AC4-A11A-8C05431F3CFAQ35752353-0E8A7A7C-87D1-4D0B-B356-D2A129565627Q36200469-30D7E811-9807-4BF2-8FF4-45BC9541BFBDQ36466472-7470334C-AFD8-4C51-BC7E-5B7A0FF079E7Q37103046-A849D86F-A392-49AA-9FA1-3B491F6172B9Q37206150-59857808-B6FD-458D-9495-004FBC8AFBA6Q37294049-8967E69F-A7EA-4E26-9203-27111FD805FAQ37713734-214B68A6-C6E0-42D5-BD7D-3AFA1AD3E3C9Q38206125-F0B10D72-B631-4AA1-AB5B-ACBAE2422948Q40174843-A40E3CAD-22F2-4B74-991B-C34D0931033CQ40185578-03F7269D-8E35-4543-9326-D193BB09A27CQ42862310-4DFFEA91-321C-426A-96D6-11CBFBBB2E8CQ58795487-7965AA0E-7C77-4BFE-B3CE-8DC3DD4B7A5DQ58923297-60A7BF6D-DE8F-45A3-AF86-16127EF3A7E4
P2860
Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@ast
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@en
type
label
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@ast
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@en
prefLabel
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@ast
Alteration of caspases and apo ...... ents with Alzheimer's disease.
@en
P2093
P356
P1476
Alteration of caspases and apo ...... ients with Alzheimer's disease
@en
P2093
P356
10.1006/BBRC.2001.4306
P407
P577
2001-02-01T00:00:00Z